Quick Answer
Mirum Pharmaceuticals, Inc. reported Shares Outstanding of 51.90 million shares for fiscal year 2025.
Mirum Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 51.90M | +7.4% |
| 2024 | 48.34M | +3.5% |
| 2023 | 46.72M | +26.4% |
| 2022 | 36.96M | +20.8% |
| 2021 | 30.58M | +2.7% |
| 2020 | 29.78M | +31.8% |
| 2019 | 22.60M | +3449.5% |
| 2018 | 636,719 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 51.31M | +7.0% | +2.5% |
| June 30, 2025 | 50.06M | +5.2% | +1.2% |
| March 31, 2025 | 49.45M | +5.1% | +2.3% |
| December 31, 2024 | 48.34M | +3.5% | +0.8% |
| September 30, 2024 | 47.97M | +2.9% | +0.8% |
| June 30, 2024 | 47.57M | +24.5% | +1.1% |
| March 31, 2024 | 47.06M | +23.8% | +0.7% |
| December 31, 2023 | 46.72M | +26.4% | +0.3% |
- Mirum Pharmaceuticals, Inc. showed an increase of +7.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Mirum Pharmaceuticals, Inc.’s shares outstanding has grown by 8050.6% (from 636.7 thousand shares to 51.90 million shares).
- The most recent figure is from Mirum Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: